Labshake search
Citations for Peprotech :
351 - 400 of 1787 citations for Recombinant Human CD79B protein Fc tagged APC labeled since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Genomics 2023Quote: ... and 100 ng/mL recombinant human M-CSF (Peprotech, 3002510UG) at 37°C ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with 200 U/ml recombinant human IL-2 (Peprotech). One day after activation ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 ng mL−1 recombinant human NT-3 (PeproTech)) ...
-
bioRxiv - Immunology 2023Quote: ... and 3000IU/mL recombinant human IL2 (PeproTech, Cat# 200-02) and cultured at 37◦C with 5% CO2 for 15-23 days ...
-
bioRxiv - Cancer Biology 2023Quote: ... recombinant human EGF (20 ng/mL, PeproTech, AF-100-15), recombinant human FGF-basic (20 ng/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... recombinant human FGF-basic (20 ng/mL, PeproTech, 100-18B), and 1% Penicillin-Streptomycin (Gibco ...
-
bioRxiv - Cancer Biology 2023Quote: ... 200 U/mL recombinant human IL-2 (PeproTech, 200-02), and 1% penicillin-streptomycin 100X solution (Cytiva ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... and animal-Free Recombinant Human EGF from PeproTech (Cranbury, NJ). Propidium iodide was from Invitrogen (Waltham ...
-
bioRxiv - Physiology 2024Quote: ... and recombinant human noggin 50 ng/mL (Peprotech, #120-10C). Organoids were cultured at 37 °C in 5% CO2 in initiation media for 72 hr ...
-
bioRxiv - Biochemistry 2024Quote: ... and 2 ng/ml Recombinant Human GDNF (Peprotech 450-10).
-
bioRxiv - Biophysics 2024Quote: ... and 200 IU/mL of recombinant human IL-2 (PeproTech). The cells were re-stimulated with 100 IU/mL recombinant human IL-2 every 2 to 3 days.
-
bioRxiv - Bioengineering 2024Quote: ... MSCs were treated with human recombinant IFNγ (PeproTech, Cranbury, NJ) at a concentration of 50ng/mL for 24 hours where indicated.
-
bioRxiv - Cancer Biology 2024Quote: ... Recombinant Human IFN-γ was obtained from Peprotech (300-02).
-
bioRxiv - Physiology 2023Quote: Recombinant human GH from Peprotech (Cat # 100-40; Cranbury, NJ) was reconstituted in PBS at a concentration 0.2 μg/μL ...
-
bioRxiv - Immunology 2022Quote: ... To treat human organoids in vitro we used recombinant human IFNλ-2 (300-02K; Peprotech). The following antibodies were used for immunoblotting ...
-
bioRxiv - Cell Biology 2019Quote: ... recombinant human R-spondin-1 (120-38) and recombinant murine Noggin (250-38) were from Peprotech (NJ, USA). Matrigel® with reduced growth factors (356231 ...
-
bioRxiv - Developmental Biology 2021Quote: ... and 10 ng/μl recombinant human TGF-β1 (Peprotech, 100-21) were added to the medium instead of adding SB431542 and Noggin to activate dual SMAD signalling (Extended Data Fig ...
-
bioRxiv - Developmental Biology 2020Quote: ... Naïve conditions for murine ESCs included 10μg recombinant human LIF (Peprotech) and small-molecule inhibitors CHIR99021 (CH ...
-
bioRxiv - Immunology 2022Quote: ... The other recombinant human chemokines were obtained from Peprotech (Hamburg, Germany). All other reagents and chemicals were purchased from Merck KGaA (Darmstadt ...
-
bioRxiv - Microbiology 2022Quote: ... and 2*105 units/ml Recombinant Human FGF-basic (PeproTech Inc.). HCMV-pp150-EGFP-gM-mCherry was a kind gift by Christian Sinzger [32] ...
-
bioRxiv - Molecular Biology 2020Quote: ... IGF-1 (100 ng ml-1; recombinant Human IGF-1, Peprotech, Cat#100-11 ...
-
bioRxiv - Microbiology 2020Quote: ... 10 ng/mL recombinant human tumor necrosis factor (TNF-α, Peprotech) was added to the medium to induce phenotypic and functional maturation ...
-
bioRxiv - Immunology 2021Quote: ... supplemented with recombinant human IL-6 (50 ng mL-1; Peprotech), human IL-3 (10 ng mL-1 ...
-
bioRxiv - Cancer Biology 2019Quote: ... Recombinant human IL-6 was purchased from PeproTech (Rocky Hill, NJ). Enzyme-linked immunosorbent array (ELISA) ...
-
bioRxiv - Cancer Biology 2019Quote: ... Recombinant-human IL2 and IL15 (Peprotech #200-02 and #200-15) were included as controls ...
-
bioRxiv - Cancer Biology 2019Quote: ... 50 ng/mL human recombinant EGF (Peprotech, Rocky Hill, NJ, USA), 500 nM A83-01 (Tocris ...
-
bioRxiv - Neuroscience 2019Quote: ... and 70 µg recombinant human brain-derived neurotrophic factor (BDNF; PeproTech) were prepared in saline ...
-
bioRxiv - Immunology 2021Quote: ... and 100 ng/mL recombinant human M-CSF (rhM-CSF, PeproTech). The hemogenic endothelium transitioned into monocyte factories and produced non-adherent CD14+ monocytes that can be harvested repeatedly starting around day 21 ...
-
bioRxiv - Bioengineering 2020Quote: ... recombinant human TGF-β1 (5 ng/ml, Peprotech, Rocky Hill, NJ) was supplemented into the media at 5 ng ml-1 ...
-
bioRxiv - Neuroscience 2021Quote: ... and 50ng/mL recombinant human/murine/rat BDNF (PeproTech, #450-02) were added to slices with 3μM puromycin (Tocris #40-895-0 ...
-
bioRxiv - Neuroscience 2020Quote: ... neurons were treated with 50 ng/ml human recombinant BDNF (Peprotech) or with a mixture of 25 mM KCl and 5 μM NMDA receptor antagonist D-2-amino-5-phosphopentanoic acid (D-APV ...
-
bioRxiv - Cell Biology 2021Quote: ... Cultures were supplemented with human recombinant 50 ng/ml TPO (Peprotech), 20 ng/ml human recombinant IL-6 (STEMCELL Technologies ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human G-CSF (300-23, Peprotech, lots: 041777 and 041877) was reacted with sulfo-Cy5 NHS ester (13320 ...
-
bioRxiv - Bioengineering 2022Quote: ... 20-ng/mL recombinant human IFN-γ (Peprotech, Rocky Hill, NJ), and 100-ng/mL lipopolysaccharide (LPS ...
-
bioRxiv - Bioengineering 2022Quote: ... 1 ng/mL human recombinant tumor necrosis factor-α (TNF; PeproTech) was introduced to the medium after confluency was achieved and the TEER was recorded every 2 hours ...
-
bioRxiv - Cancer Biology 2022Quote: ... Recombinant human IL-1β and IL-3 was purchased from PeproTech. TLR-5 was purchased from Invivogen ...
-
bioRxiv - Developmental Biology 2021Quote: ... 10 ng/mL of recombinant human LIF (Cat. 300-05, Peprotech), and 2 µM of Gö6983 (Cat ...
-
bioRxiv - Microbiology 2021Quote: ... and 20 ng/ml recombinant human IL6 (rhIL6) (all from Peprotech) 16 to 24 hours prior to transduction ...
-
bioRxiv - Neuroscience 2020Quote: ... Recombinant human FGF-8 was added at 100 ng/ml (Peprotech) until day 7 ...
-
bioRxiv - Neuroscience 2022Quote: ... 20 ng/mL human recombinant basic fibroblast growth factor (bFGF, PeproTech) and 10 µM all-trans retinoic acid (Sigma-Aldrich) ...
-
bioRxiv - Immunology 2022Quote: ... life technologies)+10% FBS+20U/ml recombinant human IL-2 (PeproTech)+ 5μg/ml anti-CD28 (Invitrogen) ...
-
bioRxiv - Immunology 2022Quote: ... human recombinant Fms-related tyrosine kinase 3 ligand (FLT3-L) (PeproTech) until injection in mice (within 3 to 6 hours of culture ...
-
bioRxiv - Cell Biology 2022Quote: ... Recombinant human VEGF-A165 was purchased from Peprotech (Cranbury, NJ, USA)
-
bioRxiv - Cancer Biology 2022Quote: ... Tgf-B treatment: Recombinant Human TGF-B1 (PeproTech catalog #: 100-21) was added to enteroid media on Day 0 for final concentration of 0 ...
-
bioRxiv - Immunology 2019Quote: ... Cells were stimulated with 20 ng/ml recombinant human TNF (PeproTech). Drug treatments were administered 15 minutes after TNF exposure to both the top and bottom wells of the transwell system to achieve the stated final concentrations ...
-
bioRxiv - Cancer Biology 2020Quote: ... mice were treated with human recombinant Amphiregulin (Cat# 100-55B, Peprotech) dissolved in 0.1% BSA (Sigma ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 20 ng/ml recombinant human fibroblast growth factor (hFGF; PeproTech) and 2 µg/ml heparin sulfate ...
-
bioRxiv - Molecular Biology 2019Quote: ... Naïve conditions for murine ESCs included 10μg recombinant human LIF (Peprotech) and small-molecule inhibitors CHIR99021 (CH ...
-
bioRxiv - Bioengineering 2021Quote: ... recombinant human fibroblast growth factor 2 (hFGF-2, Peprotech, 100-18B), recombinant human epidermal growth factor (hEGF ...
-
bioRxiv - Cancer Biology 2021Quote: ... For cultures treated with exogenous human recombinant NGF (Peprotech 450-01) and human recombinant MMP3 (Peprotech 420-03) ...